Blog
American Liver Foundation (ALF) is excited to once again team up with James Beard Award-winning Chef Christopher Gross of Christopher’s and Executive Pastry Chef Joel Gonzalez of Fairmont Scottsdale Princess for FLAVORS, a national culinary event, taking place on Wednesday, April 15, 2026, at the Arizona Biltmore, 2400 E. Missouri, in Phoenix, Arizona.
April is officially recognized as National Donate Life Month, a time when American Liver Foundation (ALF) joins the nation in honoring those willing to give the gift of life through organ donation.
American Liver Foundation (ALF) is excited to announce the election of David Frank as its new chair of the board. David, who has served as Vice Chair of ALF’s board since March of 2025, is the Senior Product Manager for Equities Cash & Derivatives at Wells Fargo Securities in NYC.
American Liver Foundation (ALF) applauds the Agency for Healthcare Research and Quality (AHRQ) on their groundbreaking report that assesses the prevalence of nonalcoholic fatty liver disease (NAFLD), now called metabolic dysfunction-associated steatotic liver disease (MASLD)*.
American Liver Foundation (ALF) brings its Bili the Brave™ children’s book to life through a beautiful, animated video with narration by CNN political commentator and attorney Bakari Sellers and his 7-year-old daughter Sadie Sellers, a biliary atresia (BA) patient and liver transplant recipient.
Leading medical experts and patient advocates came together last week for a Congressional Briefing hosted by American Liver Foundation (ALF) on Liver Cancer: Prevalence, Risk Factors, and Strategies for Prevention and Treatment.
American Liver Foundation (ALF) proudly announces its 50th anniversary, marking five decades of unwavering commitment to advancing liver health, empowering liver patients and their families, providing groundbreaking public health initiatives and programs, and funding close to $30 million in critical research that supports and educates the 100 million Americans living with some form of liver disease.
ALF is deeply disappointed that the Advisory Committee on Immunization Practices (ACIP) voted this morning to end the highly effective universal hepatitis B (hep B) birth dose recommendation for infants.
American Liver Foundation (ALF) is thrilled to announce the recipients of its 2025 research awards totaling an historic $1.1M in funding to support early-career scientists, post-doctoral trainees and junior faculty who are providing cutting-edge research in basic, translational and clinical projects.
American Liver Foundation (ALF) is pleased to announce a new partnership with Helio Genomics (Helio) that empowers millions of Americans to find out if they are at risk for, or already have, liver cancer.
ALF is deeply disappointed that the Advisory Committee on Immunization Practices (ACIP) voted this morning to end the highly effective universal hepatitis B (hep B) birth dose recommendation for infants.
Virtual and in-person event, Bridging Basic Science and Liver Disease, brings together hundreds of leading biomedical scientists and physicians from across the globe.